ap RIV1.5 (Rivastigmine Tartrate 1.5 mg)
Pill with imprint ap RIV1.5 is Yellow, Capsule-shape and has been identified as Rivastigmine tartrate 1.5 mg. It is supplied by Ajanta Pharma Limited.
Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ap RIV1.5
Rivastigmine tartrate
- Imprint:
- ap RIV1.5
- Strength:
- 1.5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Ajanta Pharma Limited
- National Drug Code (NDC):
- 27241-0090
More about rivastigmine
- Rivastigmine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 21 Reviews – Add your own review/rating
- Drug class: cholinesterase inhibitors
Consumer resources
- Rivastigmine
- Rivastigmine transdermal
- Rivastigmine Capsules
- Rivastigmine Oral Solution
- Rivastigmine Patch
- ... +2 more
Other brands: Exelon
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
